Yolanda Lage

Management of Intracranial Metastases in EGFR-Mutated NSCLC: A Review of Literature following an Unusual Case Report

P. Garrido, P. Gajate, J. Esteban, 2021, Case reports in oncological medicine.

New horizons for uncommon mutations in non-small cell lung cancer: BRAF, KRAS, RET, MET, NTRK, HER2

X. Mielgo-Rubio, F. Couñago, L. Cabezón-Gutiérrez, 2022, World journal of clinical oncology.

Targeting KRAS in Non-Small Cell Lung Cancer

P. Garrido, E. Corral de la Fuente, Yolanda Lage, 2022, Frontiers in Oncology.

Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments

A. Carrato, F. Longo, J. Casado, 2022, European Journal of Cancer.

Acute anti-Ma2 paraneoplastic encephalitis associated to pembrolizumab: a case report and review of literature

P. Garrido, A. Soria, J. Pozas, 2021, Translational lung cancer research.

Immune checkpoint inhibitors-associated thrombosis in patients with lung cancer and melanoma: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group

A. M. Martin, D. Lavin, J. R. Pérez, 2022, Clinical and Translational Oncology.

Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient Treated with a Novel Combination Treatment with Anti PDL1 Antibody (Durvalumab) and VEGFR2 Antibody (Ramucirumab)

J. García-Foncillas, V. Moreno, A. Rupérez, 2019, Archives of Clinical and Medical Case Reports.